Patent 11446477

Derivative works

Defensive disclosure: derivative variations of each claim designed to render future incremental improvements obvious or non-novel.

Active provider: Google · gemini-2.5-flash

Derivative works

Defensive disclosure: derivative variations of each claim designed to render future incremental improvements obvious or non-novel.

✓ Generated

Defensive Disclosure for US Patent 11446477

This document outlines various derivative works and technical disclosures related to US Patent 11446477, "Devices and methods for treating skin," with the strategic aim of establishing prior art that could render future incremental improvements by competitors obvious or non-novel. The derivatives are framed around core independent claims of US11446477 and explore material/component substitution, operational parameter expansion, cross-domain applications, integration with emerging technologies, and inverse/failure modes.

Derivatives for Independent Claim 1: Apparatus for Treating Skin

(Claim 1: A skin treatment apparatus comprising a console with a user input device, a handpiece for treating skin, a fluid line providing fluid communication between the console and the handpiece, and a manifold system coupled to the console and controlled by the user input device, configured to hold releasably a plurality of fluid sources and deliver fluid from at least one of the plurality of fluid sources to the handpiece assembly.)

1.1 Material & Component Substitution: Advanced Biocompatible System

Enabling Description: A skin treatment apparatus where the console housing is constructed from a reinforced carbon-fiber composite with integrated EMI shielding, reducing device footprint and enhancing durability. The fluid lines, including the supply and waste lines (50, 52), are manufactured from medical-grade perfluoroalkoxy alkanes (PFA) for enhanced chemical resistance and minimal leachables. The handpiece assembly (18) main body (30) is precision-machined from titanium alloy (e.g., Ti-6Al-4V) to reduce weight and improve sterilization capability, with all seals (e.g., 47) made from medical-grade liquid silicone rubber (LSR) for improved flexibility and chemical inertness. Fluid sources (26) are sterile, single-use, gamma-sterilizable high-density polyethylene (HDPE) pouches integrated with an active RFID tag for automated identification within the manifold system (24). The internal pump components (not explicitly numbered but implied by manifold system and fluid delivery) are fabricated from ceramic (e.g., zirconia) for increased longevity and precision with corrosive fluids.

graph TD
    A[Carbon-Fiber Console Housing] --> B(User Input Device);
    B --> C{Manifold System};
    C --> D(PFA Fluid Lines);
    D --> E[Titanium Handpiece Assembly];
    E --> F[Skin Treatment];
    C -- RFID ID --> G[HDPE Fluid Pouches];
    C --> H[Zirconia Pump Components];
    D -- Waste Flow --> C;

1.2 Operational Parameter Expansion: High-Throughput Therapeutic System

Enabling Description: A skin treatment apparatus designed for industrial-scale dermatological treatment or rapid full-body decontamination. The fluid lines (20) are scaled to 25mm internal diameter with corresponding high-flow pumps (e.g., peristaltic pumps capable of 10 L/min) and wide-bore handpiece assemblies (18) with treatment tips (34) having a contact area of 100 cm². The system operates with treatment fluid temperatures ranging from 0°C (for cryo-therapy) to 60°C (for hyper-thermotherapy) via integrated Peltier elements and fluid heaters (not shown, within console 12). Fluid pressures within the handpiece delivery system can reach up to 10 bar for high-velocity liquid jet applications, and vacuum levels can exceed -90 kPa (relative) for enhanced tissue lifting and extraction over large surface areas. The console (12) is capable of managing continuous operation for 24+ hours.

graph TD
    A[Console w/ User Input] --> B(High-Flow Pumps);
    B --> C{Fluid Heaters/Coolers};
    C --> D[25mm PFA Fluid Lines];
    D --> E[Wide-Bore Handpiece (100cm² Tip)];
    E --> F[Industrial Skin Treatment];
    G[Fluid Sources] --> B;
    E -- 0-60C, 10 bar, -90kPa --> F;

1.3 Cross-Domain Application: Precision Coating Application in Automotive

Enabling Description: The apparatus is adapted for precision application of protective coatings or sealants on automotive body panels. The console (12) and user input device (32) control a manifold system (24) capable of holding various coating formulations (e.g., clear coats, rust inhibitors, waxes) as fluid sources (26). A fluid line (20) delivers the selected coating to a robotic arm-mounted handpiece assembly (18) equipped with a non-abrasive, non-contact spray tip (34). The tip is configured for electrostatic or ultrasonic atomization, ensuring uniform coating thickness and minimal overspray. The manifold system can also manage cleaning solvents for automated purging of the lines between different coating applications.

graph TD
    A[Console (Robotic Control)] --> B(User Input Device);
    B --> C{Manifold System};
    C --> D[Coating Fluid Lines];
    D --> E[Robotic Handpiece (Spray Tip)];
    E --> F[Automotive Body Panel Coating];
    C -- Select/Deliver --> G[Coating Formulations];
    C -- Cleaning Solvents --> D;

1.4 Integration with Emerging Tech: AI-Driven Smart Dermatological System

Enabling Description: An apparatus where the console (12) integrates an AI inference engine (e.g., deep learning model) that processes real-time data from multispectral IoT sensors (e.g., skin impedance, hydration, sebum levels, microscopic imaging) embedded in the handpiece tip (34). The AI dynamically optimizes treatment parameters (e.g., fluid type, flow rate, vacuum pressure, tip contact force, oscillation frequency) based on immediate skin response and a pre-programmed patient profile, adjusting the manifold system (24) and pump (not shown, in console) accordingly. Blockchain technology (e.g., Hyperledger Fabric) is utilized for immutable recording of treatment protocols, fluid source batch numbers, and tip usage history, ensuring supply chain verification, anti-counterfeiting measures for treatment fluids, and compliance auditing. Each fluid container (26) is equipped with a unique, cryptographically signed digital certificate stored on the blockchain.

graph TD
    A[Console w/ AI Engine] --> B(User Input Device);
    B --> C{Manifold System};
    C --> D[Fluid Lines];
    D --> E[Handpiece w/ IoT Sensors];
    E -- Real-time Skin Data --> A;
    C -- Fluid Selection/Flow --> D;
    F[Fluid Sources w/ Digital Certs] --> C;
    A -- Optim. Parameters --> C;
    A -- Immutable Log --> G[Blockchain Ledger];
    E -- Usage Data --> G;
    F -- Batch Data --> G;

1.5 The "Inverse" or Failure Mode: Fail-Safe Diagnostic System

Enabling Description: A skin treatment apparatus designed to prioritize patient safety and diagnostic functionality. In a failure mode (e.g., detected fluid line blockage, pump malfunction, or excessive skin suction), the system automatically defaults to a "drain-only" or "low-power diagnostic" mode. In "drain-only," all fluid delivery to the handpiece (18) is immediately ceased, and a dedicated waste pump activates to rapidly evacuate any residual fluid or air from the fluid lines (20) and handpiece, preventing unwanted fluid application or pressure buildup. In "low-power diagnostic," the fluid delivery system is deactivated, the handpiece operates solely as a skin scanning device utilizing non-invasive optical sensors (e.g., dermatoscope, hydration sensors) at minimal power consumption, allowing for continued skin assessment without active treatment or fluid dispensation. The manifold system (24) automatically diverts all fluid paths to a dedicated bypass for saline rinse in case of fluid contamination alarm.

stateDiagram
    [*] --> Idle: Power On
    Idle --> Active_Treatment: User Starts Treatment
    Active_Treatment --> Fail_Safe_Drain: Blockage/Malfunction
    Active_Treatment --> Low_Power_Diagnostic: System Error
    Fail_Safe_Drain --> Idle: System Reset
    Low_Power_Diagnostic --> Idle: Diagnostic Complete
    Idle --> Saline_Bypass: Contamination Detected
    Saline_Bypass --> Idle: Flush Complete

Derivatives for Independent Claim 16: Treatment Tip

(Claim 16: A tip comprising a skirt portion configured to couple to a handpiece for treating a target area on a patient's skin, a central body portion coupled to the skirt portion, a first passage extending through the central body portion and configured to receive a fluid from the handpiece, at least one second passageway extending through the central body portion and configured to convey the fluid back into the handpiece, and an inner member extending in a generally spiral fashion across at least a portion of a distal face of the central body portion, the inner member defining a channel between the first passage and the at least one second passage, wherein when the tip is place against the skin, a chamber can be formed by the channel and the person's skin.)

2.1 Material & Component Substitution: Advanced Ceramic-Polymer Spiral Tip

Enabling Description: A treatment tip (34) where the skirt portion (64) and central body portion (66) are monolithically molded from a medical-grade, high-strength polyether ether ketone (PEEK) composite, offering superior chemical resistance to diverse treatment fluids and improved autoclave sterilization cycles. The inner member (124) is formed from a biocompatible ceramic (e.g., yttria-stabilized zirconia) via additive manufacturing, which is then chemically bonded or thermally fused to the PEEK body. This ceramic inner member can incorporate micro-texturing (e.g., diamond-like carbon coating or etched patterns) for enhanced abrasion or specific surface energy to modulate fluid flow and interaction with the stratum corneum. The first passage (122) and second passageway (114) are lined with an ultra-hydrophilic coating (e.g., plasma-polymerized polyethylene glycol) to minimize fluid adherence and improve flow efficiency.

graph TD
    A[PEEK Skirt & Central Body] --> B(Ceramic Spiral Inner Member);
    A --> C(Hydrophilic Lined Passages);
    B -- Micro-texturing --> D(Enhanced Abrasion/Fluid Mod.);
    C -- Fluid In --> E(Skin Chamber);
    E -- Fluid Out --> C;
    A -- Coupling --> F[Handpiece];

2.2 Operational Parameter Expansion: Microfluidic Opto-Acoustic Tip

Enabling Description: A treatment tip featuring microfluidic channels in a spiral geometry, fabricated using two-photon polymerization for precise control over channel dimensions down to 10-50 micrometers. This enables highly localized fluid delivery and waste removal for sub-dermal or intracellular treatments. The tip integrates an array of micro-electromechanical system (MEMS) ultrasonic transducers along the inner member (124) to generate localized acoustic cavitation (20-100 kHz) within the fluid channel (140), enhancing exfoliation and transdermal permeation of active ingredients without gross mechanical abrasion. Furthermore, the tip incorporates fiber-optic light guides that terminate along the spiral path, allowing for pulsed laser irradiation (e.g., 532 nm or 1064 nm) of the skin concurrent with fluid flow for photothermal or photoacoustic effects, controlled at frequencies up to 100 Hz.

graph TD
    A[Microfluidic Spiral Tip] --> B(MEMS Ultrasonic Transducers);
    A --> C(Fiber-Optic Light Guides);
    B -- Acoustic Cavitation --> D(Enhanced Exfoliation);
    C -- Pulsed Laser --> E(Photothermal/Photoacoustic);
    A -- Fluid In/Out --> F[Localized Skin Treatment];
    D --> F;
    E --> F;

2.3 Cross-Domain Application: Precision Etching in Micro-Electronics Fabrication

Enabling Description: The treatment tip's design is adapted for precision chemical-mechanical planarization (CMP) or etching of semiconductor wafers. The skirt portion (64) couples to a robotic arm. The central body (66) features an inner member (124) with a spiral channel (140) fabricated from a chemically inert material (e.g., silicon carbide or sapphire). A first passage delivers etching or CMP slurry (fluid from handpiece) to the wafer surface. The spiral channel ensures uniform distribution and controlled residence time of the chemical agent across the wafer, while simultaneously providing controlled mechanical action via micro-abrasive features on the spiral surface. The second passageway (114) is used for efficient removal of spent slurry and etched material, minimizing redeposition and ensuring a clean process. The tip includes integrated conductivity and pH sensors to monitor the slurry conditions in real-time.

graph TD
    A[Robotic Arm] --> B(SiC/Sapphire Etching Tip);
    B -- Slurry In --> C{Spiral Channel};
    C -- Etching/CMP --> D[Semiconductor Wafer];
    C -- Slurry Out --> E(Waste Collection);
    B -- Sensors --> F(Process Control System);

2.4 Integration with Emerging Tech: AI-Enhanced Adaptive Exfoliation Tip

Enabling Description: A treatment tip (34) integrates a suite of miniature IoT sensors along the distal face, including a microscopic camera (e.g., for stratum corneum morphology), a spectroscopic sensor (e.g., Raman or near-infrared for chemical composition), and a tactile pressure sensor array. An embedded microcontroller processes this real-time data and transmits it wirelessly via a low-power Bluetooth Low Energy (BLE) module to the main console's AI engine. The AI dynamically adjusts the physical parameters of the tip: a variable-pitch spiral inner member (124) (e.g., actuated by micro-solenoids or shape memory alloys) can change the channel's tightness to modulate fluid detention time and abrasive contact. The abrasion level of the inner member can be varied via localized electro-chemical dissolution or deposition of a sacrificial abrasive layer. Furthermore, the tip utilizes a blockchain-enabled non-fungible token (NFT) for each tip, certifying its authenticity, manufacturing batch, and tracking its cumulative usage and sterilization cycles against a smart contract for quality assurance and fraud prevention.

graph TD
    A[Tip w/ IoT Sensors] --> B(Embedded Microcontroller);
    B -- Wireless BLE --> C[Console AI Engine];
    A -- Variable Pitch Spiral Actuator --> D(Fluid Detention Control);
    A -- Electro-Chemical Abrasive Layer --> E(Abrasion Level Control);
    A -- NFT (Authenticity/Usage) --> F[Blockchain Ledger];
    C -- Real-time Adj. --> D;
    C -- Real-time Adj. --> E;
    D --> G[Skin Treatment];
    E --> G;

2.5 The "Inverse" or Failure Mode: Gentle Fluidic Massage Tip with Controlled Pressure Release

Enabling Description: A treatment tip specifically designed for gentle fluidic massage and lymphatic drainage, explicitly avoiding abrasive action. The inner member (124) is constructed from a soft, compliant, medical-grade silicone with rounded, non-abrasive edges. The spiral channel (140) is wider and shallower, optimized for even fluid distribution and gentle suction rather than localized abrasion. The tip incorporates an active micro-valve system within the skirt portion (64) connected to a pressure sensor. If the pressure differential between the tip's interior chamber (formed with skin) and ambient pressure exceeds a predefined safe threshold (e.g., indicating excessive suction or skin pulling), the micro-valve passively or actively opens to relieve the vacuum, preventing skin trauma or excessive tissue deformation. This allows for controlled "low-functionality" operation where the primary goal is gentle fluid delivery and removal for skin conditioning, hydration, or lymphatic stimulation.

graph TD
    A[Compliant Silicone Tip] --> B(Soft, Rounded Inner Member);
    A --> C(Wide, Shallow Spiral Channel);
    A -- Pressure Sensor --> D(Active Micro-Valve System);
    C -- Gentle Fluid Flow --> E[Skin Massage/Lymphatic Drainage];
    D -- Pressure Relief --> E;
    A -- Coupling --> F[Handpiece];

Derivatives for Independent Claim 20: Method of Treating with Spiral Tip

(Claim 20: A method of treating a target region on a patient's skin comprising providing a tip including a first aperture and at least one second aperture, at least one inner member on the surface of the tip defining at least one channel between the first aperture and the at least one second aperture, and an outer member disposed on the surface of the tip; engaging the target with the tip such that the outer member engages the target; flowing a treatment fluid distally through the first aperture region and through the at least one channel; and flowing the treatment fluid proximally through the at least one second aperture.)

3.1 Material & Component Substitution: Enzyme-Catalyzed Bio-Exfoliation Method

Enabling Description: A method of treating skin using a tip (as per Claim 16) where the "treatment fluid" is an enzyme-based exfoliant (e.g., papain, bromelain, or bacterial collagenase) stabilized in a low-viscosity buffer. The inner member (124) of the tip is fabricated from a non-abrasive, highly inert polymer (e.g., PTFE or PFA) to minimize mechanical irritation. The method involves engaging the skin with the tip, allowing the enzyme solution to flow distally through the first aperture (122) and dwell within the spiral channel (140) for a precisely controlled contact time (e.g., 30-180 seconds, optimized for enzyme kinetics), facilitated by the spiral path. During this dwell time, the outer member (120) maintains a sealed chamber, allowing the enzymes to chemically digest dead skin cells. The spent enzyme solution and exfoliated debris are then efficiently removed proximally through the second aperture (114). Subsequent steps may involve flowing a neutralizing agent or rinse solution.

sequenceDiagram
    participant P as Patient Skin
    participant T as Spiral Tip
    participant H as Handpiece
    participant C as Console
    C->H: Deliver Enzyme Fluid
    H->T: Flow Fluid Distally (Aperture 1)
    T->P: Engage Skin (Outer Member Seal)
    P-->>T: Form Chamber w/ Spiral Channel
    T->P: Enzyme Dwell Time (Chemical Exfoliation)
    H->T: Flow Fluid Proximally (Aperture 2)
    T->P: Remove Spent Enzyme/Debris
    H->C: Return Waste

3.2 Operational Parameter Expansion: Cryo-Ablative Liquid Nitrogen Method

Enabling Description: A method leveraging a tip with specialized cryogenic fluidic pathways (e.g., vacuum-insulated stainless steel or PEEK-lined channels). The "treatment fluid" is liquid nitrogen (LN2) or a controlled LN2 vapor stream, delivered at temperatures between -196°C and -100°C. The method involves briefly engaging the target skin region with the tip. LN2 flows distally through the first aperture, across the spiral channel, and rapidly cools the targeted skin layer, inducing controlled cryo-necrosis or cryo-peeling. The spiral channel geometry is optimized to create a uniform cold front and control the exposure time for precise depth of tissue effect. The evaporated nitrogen and ablated tissue are immediately drawn proximally through the second aperture into a cryo-waste collection system, preventing unwanted dermal damage or frostbite to adjacent areas. This high-frequency application (e.g., pulsed LN2 bursts at 5-10 Hz) enables precise cryo-ablation.

graph TD
    A[Cryo-Regulated Console] --> B(Cryogenic Fluid Pump);
    B --> C[Vacuum-Insulated Fluid Line];
    C --> D{Specialized Cryo-Tip};
    D -- LN2 Distally --> E(Skin Target Region);
    E -- Cryo-Ablation (Spiral Path) --> F(Ablated Tissue/Vapor);
    F --> D;
    D -- Vapor/Waste Proximally --> G[Cryo-Waste Collection];

3.3 Cross-Domain Application: Precision Cleaning of Optical Lenses

Enabling Description: A method adapted for non-damaging, precision cleaning of delicate optical lenses or mirrors in a manufacturing setting. The "tip" is a sterile, non-contact microfluidic nozzle assembly with a spiral flow pattern, machined from optical-grade sapphire. The "treatment fluid" is a high-purity, surfactant-free deionized water (DI water) or a volatile organic solvent (e.g., isopropyl alcohol). The method involves positioning the sapphire tip above the optical surface without direct contact, creating a precisely controlled fluidic boundary layer (the "chamber") over the lens. The DI water/solvent flows distally through the first aperture, spirals across the lens surface via the defined channels (using laminar flow principles to physically dislodge particulate contaminants), and then flows proximally through the second aperture, carrying away impurities without scratching or leaving residue. This method could also integrate an inert gas curtain around the outer member to prevent re-contamination.

graph TD
    A[DI Water/Solvent Reservoir] --> B(Precision Pump);
    B --> C[Microfluidic Sapphire Nozzle];
    C -- Fluid Flow (Spiral) --> D{Optical Lens Surface};
    D -- Particulate Removal --> E(Cleaned Lens);
    C -- Fluid/Particulates Return --> F[Waste/Recycle System];

3.4 Integration with Emerging Tech: AI-Optimized Adaptive Treatment Protocol

Enabling Description: A method where the treatment fluid delivery and removal are adaptively controlled by an AI-driven system. The tip integrates real-time optical coherence tomography (OCT) and impedance sensors. As the tip engages the skin, the AI (resident in the console) analyzes the skin's real-time exfoliation progress, hydration depth, and tissue response. Based on this analysis, the AI dynamically adjusts the flow rate of the treatment fluid (e.g., salicylic acid or a hydrator) through the first aperture, the vacuum pressure applied to the second aperture, and the linear/rotational speed and pressure of the handpiece movement across the skin. This allows for personalized, real-time optimization of the exfoliation depth and fluid absorption. All treatment parameters, sensor data, and AI-driven adjustments are cryptographically logged onto a secure blockchain ledger, providing an immutable audit trail for regulatory compliance, insurance claims, and personalized patient history.

sequenceDiagram
    participant S as Skin
    participant T as Spiral Tip (w/ OCT/Impedance Sensors)
    participant A as Console AI Engine
    participant B as Blockchain Ledger
    T->S: Engage Skin
    T->A: Send Real-time Skin Data (OCT, Impedance)
    A->A: Analyze Skin State & Optimize Protocol
    A->T: Adjust Fluid Flow, Vacuum, Tip Motion
    T->S: Apply Optimized Treatment Fluid (Distally)
    S-->>T: Interact with Fluid in Channel
    T->S: Remove Fluid (Proximally)
    A->B: Log Treatment Parameters & Sensor Data
    T->B: Log Tip Usage (for NFT verification)

3.5 The "Inverse" or Failure Mode: Sub-Sensory Hydration Delivery Method

Enabling Description: A method designed for sub-sensory, continuous hydration or topical medication delivery, rather than exfoliation or abrasion. The tip features an inner member and outer member of highly polished, inert, non-abrasive material (e.g., medical-grade ceramic or diamond-polished PEEK) to ensure zero mechanical friction or exfoliation. The spiral channel is designed for extremely low flow rates (e.g., 0.1-1.0 mL/min) of a therapeutic fluid (e.g., hyaluronic acid solution, dilute corticosteroid) and very low vacuum pressure (e.g., -5 kPa relative) to create a gentle, sustained osmotic gradient. The method involves engaging the tip with the skin such that the outer member forms a subtle seal. The fluid is delivered distally, slowly permeates the skin within the channel for extended periods (e.g., 5-15 minutes per area), providing prolonged contact for passive diffusion without causing discomfort or mechanical action. In case of user error (e.g., excessive pressure), an integrated force sensor immediately triggers a shutdown of fluid flow and vacuum, reverting to a purely passive skin contact mode.

graph TD
    A[User Engagement] --> B{Tip with Force Sensor};
    B --> C{Polished Spiral Channel};
    C --> D[Low-Flow Therapeutic Fluid];
    D --> E(Gentle Osmotic Delivery to Skin);
    C -- Low Vacuum --> F(Waste Collection);
    B -- Excessive Force --> G[Shutdown Fluid/Vacuum];
    G --> H[Passive Skin Contact Mode];

Derivatives for Independent Claim 24: Treatment Tip (with Pad)

(Claim 24: A tip comprising a skirt portion configured to couple to a handpiece for treating a target on a patient's skin, a central body portion coupled to the skirt portion and includes a mounting region substantially opposite the skirt portion, the mounting region configured to receive a pad for treating the skin, a first aperture extending through the skirt portion and the central body portion and configured to receive a fluid from the handpiece, and at least one second aperture extending through the skirt portion and the central body portion and configured to convey the fluid back into the handpiece.)

4.1 Material & Component Substitution: Multi-Layer Bio-Active Pad Tip

Enabling Description: A treatment tip (34) with a mounting region (227) configured to receive a multi-layer pad (128). The pad consists of a biodegradable cellulose-based backing layer for structural integrity, a middle layer impregnated with a pH-sensitive polymer containing encapsulated active pharmaceutical ingredients (APIs, e.g., topical antibiotics, growth factors, or anti-inflammatory agents), and a distal contact layer composed of an electrospun nanofiber matrix or a micro-bristle array of medical-grade nylon or PCL for gentle exfoliation and enhanced surface area interaction. The pad attaches to the mounting surface via a non-toxic, water-soluble adhesive or a mechanical snap-fit mechanism (not explicitly numbered but commonly known). The first (122) and second (114) apertures provide fluid communication through aligned cutouts (225) in the pad, allowing carrier fluid to interact with the API layer for controlled release and simultaneously facilitating removal of spent fluid and exfoliated cells.

classDiagram
    class Tip {
        +SkirtPortion
        +CentralBodyPortion
        +MountingRegion
        +FirstAperture
        +SecondAperture
    }
    class MultiLayerPad {
        -BiodegradableBacking
        -APIMiddleLayer
        -NanoFiberContactLayer
        +Cutouts
    }
    Tip "1" *-- "1" MultiLayerPad : receives

4.2 Operational Parameter Expansion: Thermally-Modulated Ablation Pad Tip

Enabling Description: A treatment tip (34) where the pad (128) is an active thermal element. The mounting region (227) contains embedded micro-Peltier elements or resistive heating filaments that precisely control the temperature of the pad's distal surface (224) from 20°C to 80°C. The pad itself is composed of a non-abrasive, high-thermal-conductivity silicone or ceramic composite, which when heated, delivers controlled thermal energy to the skin for tissue tightening, collagen stimulation, or enhanced drug permeation (thermo-diffusion). The first (122) and second (114) apertures deliver a cooling fluid (e.g., chilled saline) that flows through internal channels within the pad to manage overall tip temperature and provide epidermal cooling, preventing unintended thermal damage while facilitating removal of any thermally altered tissue or fluid. The system allows for high-frequency pulsed thermal energy delivery (e.g., 1-10 Hz).

graph TD
    A[Handpiece] --> B(Tip w/ Mounting Region);
    B --> C{Active Thermal Pad};
    C -- Micro-Peltier/Heating Filaments --> D(Controlled Surface Temp 20-80C);
    B -- Chilled Fluid In (Aperture 1) --> C;
    C -- Heat/Fluid Exchange --> E[Skin Treatment Area];
    C -- Warm Fluid Out (Aperture 2) --> F(Waste Collection);

4.3 Cross-Domain Application: Automated Polishing Tool for Turbine Blades

Enabling Description: The tip design is adapted for automated, precision polishing and surface finishing of complex geometries, such as turbine blades in aerospace manufacturing. The skirt portion (64) couples to a multi-axis robotic polishing arm. The central body portion (66) has a mounting region (227) that receives a specific polishing pad (128) suited for different stages of finish (e.g., coarse abrasive, fine abrasive, buffing compound). The polishing pad may be constructed from specialized composite materials (e.g., diamond particle-impregnated polymers, felt, or ceramic microfiber). A first aperture (122) delivers a controlled flow of polishing compound slurry or coolant fluid to the pad-blade interface, while a second aperture (114) facilitates suction removal of spent slurry, swarf, and heat, ensuring a clean and consistent polishing process and preventing heat buildup on the delicate alloy surface.

graph TD
    A[Robotic Polishing Arm] --> B(Tool Body);
    B --> C{Tip w/ Mounting Region};
    C --> D[Interchangeable Polishing Pad];
    C -- Slurry/Coolant In --> D;
    D -- Polishing Action --> E[Turbine Blade];
    D -- Spent Slurry/Swarf Out --> F[Waste Collection];

4.4 Integration with Emerging Tech: Smart Pad System with RFID and AI Predictive Analytics

Enabling Description: A treatment tip (34) where each disposable pad (128) is embedded with a passive RFID tag containing unique identifiers (e.g., pad type, grit level, expiration date, active ingredient batch). Upon attachment to the mounting region (227), an RFID reader in the handpiece (18) or tip reads this data. This information is transmitted to the console's AI engine (12), which then validates the pad against the chosen treatment protocol and logs its usage. The AI can utilize predictive analytics based on the pad type, estimated treatment area, and real-time friction/wear sensors (embedded in the mounting region) to calculate optimal pad lifespan and recommend replacement. Blockchain technology is integrated to verify the authenticity of the RFID-tagged pads and track their lifecycle from manufacturing to disposal, providing an immutable record for anti-counterfeiting and environmental compliance. Each pad's unique ID is linked to an NFT on the blockchain.

graph TD
    A[Handpiece] --> B(Tip w/ RFID Reader);
    B --> C{Pad w/ RFID Tag};
    C -- RFID Data --> B;
    B -- Wireless --> D[Console AI Engine];
    D --> E(Pad Validation/Usage Log);
    D -- Predictive Analytics --> F(Optimal Pad Lifespan);
    C -- NFT ID --> G[Blockchain Ledger];
    F --> H(Replacement Recommendation);

4.5 The "Inverse" or Failure Mode: Ultra-Soft Diagnostic Imaging Pad Tip

Enabling Description: A treatment tip designed for purely non-abrasive, diagnostic skin imaging and fluid sampling without any exfoliation or material removal. The mounting region (227) receives an ultra-soft, transparent hydrogel pad (128) or a silicone pad with an integrated micro-lens array and low-power LED illuminators. This pad's distal surface (224) is engineered for optimal optical coupling with the skin. The first aperture (122) can deliver a non-reactive diagnostic fluid (e.g., fluorescent dye, contrast agent, or sterile saline for optical clearing) to the skin interface beneath the pad. The second aperture (114) provides gentle suction to draw off this diagnostic fluid after it has interacted with the skin, allowing for fluid-based biopsy (liquid biopsy) or collection of surface exudates without skin disruption. The pad itself can contain embedded micro-sensors for real-time pH, glucose, or lactate measurement of the collected fluid. The entire system is engineered for low contact pressure, with a built-in force limiter to prevent any unintended skin compression or abrasion.

graph TD
    A[Handpiece] --> B(Tip w/ Mounting Region);
    B --> C{Ultra-Soft Hydrogel Pad (Transparent)};
    C -- Micro-Lens Array/LEDs --> D(Skin Surface Imaging);
    B -- Diagnostic Fluid In (Aperture 1) --> C;
    C -- Gentle Interaction/Sampling --> E[Skin Target];
    C -- Fluid/Sample Out (Aperture 2) --> F[Diagnostic Fluid Collection];
    C -- Force Limiter --> G[Safe Contact Pressure];

Derivatives for Independent Claim 28: Method of Treating with Pad Tip

(Claim 28: A method of treating a target region of a patient comprises providing a tip including a first aperture, at least one second aperture, and a distal end configured to receive a pad; attaching a first pad to the distal end; and engaging the tip with the target region.)

5.1 Material & Component Substitution: Transdermal Drug Delivery via Porous Pad

Enabling Description: A method of treating a target region by providing a tip (as per Claim 24) where the attached "first pad" is a multi-layered, porous polymeric membrane (e.g., PVDF or cellulose acetate) impregnated with a specific pharmaceutical compound (e.g., an analgesic, anti-inflammatory, or hormone). This pad is designed to facilitate transdermal drug delivery. The method involves attaching this porous pad to the distal end of the tip. The tip is then engaged with the target skin region. A carrier fluid (e.g., a permeation enhancer or a buffered saline solution) is delivered through the first aperture, flowing through the pad to solubilize and activate the compound for enhanced transdermal absorption. Concurrently, a gentle vacuum through the second aperture can be used to create a localized pressure differential, further promoting drug penetration into the skin without mechanical abrasion.

sequenceDiagram
    participant P as Patient Skin
    participant T as Tip w/ Pad Mount
    participant D as Porous Drug-Delivery Pad
    participant H as Handpiece
    H->T: Attach Drug-Delivery Pad
    T->P: Engage Skin
    H->T: Deliver Carrier Fluid (Aperture 1)
    T->D: Fluid Activates/Solubilizes Drug
    D->P: Drug Transdermal Delivery
    H->T: Apply Gentle Vacuum (Aperture 2)
    T->P: Promote Penetration/Remove Excess
    H->C: Return Waste

5.2 Operational Parameter Expansion: Pulsed Electro-Hydration Method

Enabling Description: A method utilizing a tip designed with a distal end configured to receive an electro-poration pad. The "first pad" attached to the distal end is a specialized conductive hydrogel pad containing an electrolyte and embedded micro-electrodes. The method involves attaching this pad and engaging the tip with the target skin region. A treatment fluid (e.g., a highly concentrated hydrator or a vitamin serum) is delivered through the first aperture to the skin-pad interface. Simultaneously, the micro-electrodes in the pad deliver precisely controlled, short electrical pulses (e.g., 50-200 V, 10-100 microseconds duration, 1-10 Hz repetition rate) to the skin, creating temporary hydrophilic pores in the stratum corneum (electro-poration). This significantly enhances the permeation and absorption of the treatment fluid, achieving deep hydration or targeted nutrient delivery far beyond passive diffusion. The second aperture maintains a gentle vacuum to manage excess fluid and enhance contact.

graph TD
    A[Handpiece] --> B(Tip w/ Pad Mount);
    B --> C{Electroporation Hydrogel Pad};
    C -- Micro-Electrodes/Electrolyte --> D(Skin Interface);
    B -- Hydrator Fluid In --> C;
    C -- Electrical Pulses --> D;
    D -- Enhanced Permeation --> E[Deep Skin Hydration/Nutrient Delivery];
    C -- Gentle Vacuum Out --> F(Waste Collection);

5.3 Cross-Domain Application: Surface Preparation for Micro-Adhesive Bonding

Enabling Description: A method for preparing surfaces (e.g., in medical device manufacturing for micro-adhesive bonding) to ensure optimal adhesion. The tip's distal end is configured to receive a specialized surface-cleaning and activation pad. The "first pad" attached is a composite pad with a fine-grit abrasive surface and an integrated plasma-generating element or a photo-catalytic coating. The method involves attaching this pad and engaging the tip with the target bonding surface (ee.g., a biocompatible polymer component). A cleaning fluid (e.g., an ultrasonic cleaning solvent or a bio-compatible degreaser) is delivered through the first aperture and dispersed by the pad, while the abrasive surface performs micro-roughening. Simultaneously, the plasma element or UV light (activated in the pad) generates reactive species or activates the photo-catalytic coating to further clean and activate the surface chemically, improving bonding strength. The second aperture evacuates the spent fluid and particulates.

sequenceDiagram
    participant S as Surface to Bond
    participant T as Tip w/ Pad Mount
    participant P as Cleaning/Activation Pad
    participant R as Robotic Arm
    R->T: Attach P to Tip
    T->S: Engage Surface
    R->T: Deliver Cleaning Fluid (Aperture 1)
    P->S: Micro-Roughening (Abrasive)
    P->S: Chemical Activation (Plasma/Photocatalytic)
    R->T: Evacuate Spent Fluid/Particulates (Aperture 2)
    S-->>R: Ready for Bonding

5.4 Integration with Emerging Tech: Predictive Maintenance and AI-Guided Pad Attachment

Enabling Description: A method incorporating AI for guided pad attachment and real-time pad performance monitoring. The tip includes a distal end with a mounting region and integrated visual sensors (e.g., a microscopic camera) and a force-feedback haptic interface. When attaching the "first pad," the console's AI (12) provides real-time visual and haptic guidance to the user, ensuring correct alignment and optimal attachment force. After attachment, the AI continuously monitors the pad's degradation (via optical analysis from the microscopic camera and friction data from integrated sensors in the mounting region) during the treatment. The system predicts remaining pad lifespan and alerts the user for replacement, preventing suboptimal treatment. All pad attachment events, usage data, and AI-driven predictions are logged on a blockchain for verifiable maintenance records and warranty claims. Each pad has a unique QR code or NFC tag for scanning and linking to the blockchain before attachment.

sequenceDiagram
    participant U as User
    participant T as Tip w/ Sensors/Haptics
    participant C as Console AI
    participant P as Pad (w/ QR/NFC)
    participant B as Blockchain Ledger
    U->P: Scan Pad QR/NFC
    P->B: Verify Pad Authenticity/Link ID
    U->T: Attempt to Attach Pad
    T->C: Send Visual/Force Feedback
    C->U: Provide Haptic/Visual Guidance (e.g., "Adjust Angle," "Apply More Pressure")
    U->T: Attach Pad Correctly
    T->P: Engage Skin
    T->C: Send Real-time Pad Degradation Data
    C->U: Alert: "Pad nearing end-of-life"
    C->B: Log Pad Attachment/Usage/Prediction

5.5 The "Inverse" or Failure Mode: Non-Invasive Skin Barrier Assessment Method

Enabling Description: A method specifically designed for non-invasive assessment of the skin barrier function, with fluid delivery primarily for measurement rather than treatment. The tip's distal end is configured to receive a specialized biosensor pad. The "first pad" attached is a disposable, flexible biosensor array (e.g., graphene-based electrochemical sensors) designed to measure transepidermal water loss (TEWL), skin pH, and surface lipid content. The method involves attaching this biosensor pad and gently engaging the tip with the target skin region, ensuring minimal pressure. A control fluid (e.g., deionized water or a specific buffer solution) is delivered through the first aperture at extremely low flow rates to create a controlled micro-environment for sensor interaction. The biosensors in the pad then provide real-time data on skin barrier integrity, which is conveyed back through the second aperture via fluidic sampling or electrical signals for analysis by the console. This method includes safeguards: any detected force above a diagnostic threshold immediately deactivates all fluid flow and alerts the user, preventing any unintended physical interaction or skin damage.

graph TD
    A[Handpiece] --> B(Tip w/ Biosensor Mount);
    B --> C{Flexible Biosensor Pad};
    C -- TEWL/pH/Lipid Sensors --> D(Skin Barrier Assessment);
    B -- Control Fluid In (Aperture 1) --> C;
    C -- Gentle Interaction --> E[Skin Target];
    C -- Fluid Sample Out (Aperture 2) --> F[Analysis System];
    C -- Force Sensor --> G[Deactivate Fluid/Alert];

Derivatives for Independent Claim 32: Manifold System

(Claim 32: A manifold system comprising a body portion configured to receive releasably at least two bottles, the manifold is configured so that it can be coupled to a console, the console includes a handpiece for treating skin, at least one elongate member is in communication with a pump and configured to extract a fluid from one of the at least two bottles, at least one switch is configured to permit or inhibit a flow of the fluid from one of the at least two bottles through the pump.)

6.1 Material & Component Substitution: Chemically-Resistant Modular Manifold

Enabling Description: A manifold system (24) where the body portion (e.g., the structure housing quick-release locks 242 and elongate members 161) is constructed from chemically inert, high-performance polymers such as PFA or PVDF via injection molding, allowing for use with highly aggressive solvents, acids, or bases without material degradation. The components (e.g., elongate members 161) exposed to fluid are PFA or PTFE tubing. The switches (29) are solid-state microfluidic valves (e.g., based on piezoelectric actuation or micro-electromechanical systems) that provide precise, rapid, and contact-free control over fluid flow, eliminating mechanical wear and cross-contamination. The pumps (e.g., peristaltic or syringe pumps, located in the console but interfaced with the manifold) are designed with chemical-resistant wetted parts (e.g., Kalrez diaphragms). The releasable bottles (26) are made of borosilicate glass with screw caps integrating an inert septum for sterile, puncture-based fluid extraction.

graph TD
    A[PFA/PVDF Manifold Body] --> B(Solid-State Microfluidic Valves);
    A --> C(PFA/PTFE Elongate Members);
    C --> D[Borosilicate Glass Bottles];
    B --> E[Chemical-Resistant Pump];
    E --> F[Fluid Line to Handpiece];
    D -- Releasably Coupled --> A;

6.2 Operational Parameter Expansion: Ultra-High Viscosity/Temperature Manifold

Enabling Description: A manifold system designed for fluids with extreme viscosities (e.g., up to 50,000 cP) or operating temperatures (e.g., heated fluids up to 150°C). The body portion is machined from stainless steel (e.g., 316L) with integrated heating/cooling jackets (not shown but common for such applications) to maintain precise fluid temperatures within the manifold. The elongate members (161) are wide-bore, jacketed stainless steel tubes (e.g., 5mm ID) with integrated inline heaters, connected to positive displacement pumps (e.g., gear pumps or progressive cavity pumps) capable of handling highly viscous fluids and maintaining consistent flow rates. The switches (29) are high-temperature, pneumatically actuated diaphragm valves, ensuring reliable operation under thermal and viscous loads. This system could be used for applying specialized waxes, medical-grade paraffins, or high-viscosity gels.

graph TD
    A[Stainless Steel Manifold Body] --> B(Pneumatic Diaphragm Valves);
    A --> C(Jacketed SS Elongate Members);
    C --> D[Heated Bottles];
    B --> E[Positive Displacement Pumps];
    E --> F[Heated Fluid Line];
    D -- Releasably Coupled --> A;
    A -- Temp Control --> G[Integrated Heating/Cooling Jackets];

6.3 Cross-Domain Application: Automated Multi-Reagent Dispenser for Lab Automation

Enabling Description: The manifold system is adapted for high-throughput, automated dispensing of multiple chemical reagents in a laboratory automation workstation for drug discovery or materials science. The body portion (24) is integrated into a robotic liquid handling platform, configured to receive releasably standardized reagent bottles (e.g., Schott GL45 bottles). The elongate members (161) are robotic sampling probes with integrated peristaltic pumps capable of aspirating and dispensing microliter to milliliter volumes. Each bottle position features an optical sensor to verify reagent identity and volume. The "switches" (29) are electronically controlled pinch valves that precisely control the aspiration and dispense cycles from each bottle, allowing for complex reagent mixing protocols without cross-contamination. This system interfaces with a laboratory information management system (LIMS) for protocol execution and data logging.

graph TD
    A[Lab Automation Platform] --> B(Reagent Bottle Rack);
    B --> C{Reagent Bottles (GL45)};
    C -- Optical ID/Vol Sense --> B;
    B --> D[Robotic Sampling Probes];
    D -- Peristaltic Pumps --> E[Pinch Valves];
    E --> F[Reaction/Assay Plate];
    D --> G[LIMS System];

6.4 Integration with Emerging Tech: Predictive Fluid Management with AI and IoT

Enabling Description: A manifold system (24) where each bottle receiving slot includes IoT sensors for real-time fluid level, temperature, and specific gravity monitoring. This data is continuously fed to a console-resident AI engine (12) via a secure Wi-Fi or LoRaWAN connection. The AI predicts fluid depletion based on historical usage patterns, current treatment parameters, and scheduled appointments, initiating reorder alerts. The elongate members (161) feature integrated microfluidic sensors (e.g., refractive index or impedance) that verify the fluid's identity and concentration before delivery, cross-referencing against a blockchain-verified manifest for the batch. The switches (29) are smart, electronically controlled proportional valves, allowing the AI to dynamically adjust fluid mixing ratios and flow profiles based on real-time skin analytics (from the handpiece, see Claim 1). Every fluid dispense event, sensor reading, and AI decision is recorded with cryptographic timestamps on a distributed ledger (blockchain), ensuring unparalleled transparency, traceability, and accountability in the supply chain and treatment history.

graph TD
    A[Manifold Body w/ IoT Sensors] --> B(Fluid Bottles w/ IDs);
    B -- Real-time Data --> C[Console AI Engine];
    C -- Predicted Depletion --> D(Reorder Alerts);
    A -- Microfluidic Sensors (Elongate Member) --> C;
    C -- Fluid Verification --> E[Blockchain Manifest];
    A -- Proportional Valves --> F[Fluid Lines];
    C -- Control/Adjust --> F;
    F -- Dispense Event --> G[Blockchain Ledger];

6.5 The "Inverse" or Failure Mode: Fail-Safe Fluid Isolation Manifold

Enabling Description: A manifold system designed with an inherent "fail-safe" mode focusing on preventing accidental fluid mixture or leakage. The body portion (24) incorporates independent, physically separated compartments for each bottle (26), preventing cross-contamination in case of bottle rupture. The elongate members (161) are permanently sealed within their respective bottle caps, with no direct connection point to the ambient environment. The switches (29) are normally-closed, solenoid-actuated valves that require continuous power to remain open for fluid flow; upon power loss or system error, they automatically revert to a closed position, isolating each fluid source. Additionally, each bottle slot includes a leak detection sensor, triggering an immediate and complete system shutdown, disengagement of all pumps, and audible/visual alarms if any fluid is detected outside its designated containment. In a "limited-functionality" mode, the system only allows fluid extraction of a pre-selected, inert fluid (e.g., sterile water or saline) for rinsing or minimal diagnostic flushing, overriding all other fluid selections.

stateDiagram
    [*] --> Idle: Power On
    Idle --> Ready: Bottles Loaded
    Ready --> Fluid_Dispensing: Switch Activated
    Fluid_Dispensing --> Fail_Safe_Isolation: Power Loss / Leak Detected
    Fluid_Dispensing --> Limited_Functionality: System Error
    Fail_Safe_Isolation --> Idle: Manual Reset
    Limited_Functionality --> Idle: Diagnostic Mode
    Fail_Safe_Isolation --> Alarm: Leak Detected

Derivatives for Independent Claim 36: Method Using Two Tips Sequentially

(Claim 36: A method of treating a target region on a patient's skin comprises engaging a first skin treatment tip with the patient's skin, a first material is delivered out of the first skin treatment tip to a target region, and a second skin treatment tip engages the target region while the first material effectively facilitates exfoliation with the second skin treatment tip.)

7.1 Material & Component Substitution: Enzyme-Driven Chemical-Mechanical Exfoliation

Enabling Description: A method using two sequential tips for optimized exfoliation. The "first skin treatment tip" is a non-abrasive, smooth polymer tip (e.g., medical-grade polycarbonate) designed for precise application of a "first material," which is a proteolytic enzyme solution (e.g., papain, bromelain, or a mixture of bacterial proteases) in a pH-buffered delivery vehicle. This tip engages the skin to deliver the enzyme solution, allowing it to chemically loosen corneocytes. Subsequently, the "second skin treatment tip" is engaged. This second tip features a soft, high-density micro-bristle array (e.g., PBT or nylon) designed for gentle mechanical agitation. While the enzyme solution is still active on the skin, the micro-bristle tip gently scrubs the treated region, physically dislodging the enzyme-loosened dead skin cells, effectively facilitating exfoliation with minimal physical trauma. The second tip may also deliver a neutralizing or hydrating agent to complete the process.

sequenceDiagram
    participant S as Patient Skin
    participant T1 as Non-Abrasive Tip (Enzyme)
    participant T2 as Micro-Bristle Tip
    T1->S: Engage Skin
    T1->S: Deliver Proteolytic Enzyme Solution
    S->S: Enzyme Reaction (Chemical Exfoliation)
    T2->S: Engage Skin (while enzyme active)
    T2->S: Gentle Mechanical Agitation
    S->S: Physical Exfoliation of Loosened Cells
    T2->S: (Optional) Deliver Neutralizing/Hydrating Agent

7.2 Operational Parameter Expansion: Photodynamic-Enhanced Sequential Treatment

Enabling Description: A method involving a "first skin treatment tip" designed for applying a photosensitizing "first material" (e.g., aminolevulinic acid or similar porphyrin precursor) to the target skin region. This tip ensures even distribution of the photosensitizer and may include integrated low-level visible light (e.g., blue light) to initiate preliminary uptake. After a specific dwell time for the photosensitizer to be absorbed, a "second skin treatment tip" engages the same region. This second tip incorporates an array of high-intensity narrow-band light-emitting diodes (LEDs) (e.g., red light at 630 nm or blue light at 415 nm) to activate the photosensitizer, generating reactive oxygen species that selectively destroy targeted cells (e.g., acne bacteria, pre-cancerous cells) or induce collagen remodeling. Concurrently, the second tip may also deliver a protective or anti-inflammatory material, or apply gentle vacuum to remove byproducts. The light parameters (wavelength, intensity, pulse duration) are precisely controlled based on the photosensitizer and desired therapeutic effect.

graph TD
    A[Console Control] --> B(Photosensitizer Tip);
    B -- Apply Photosensitizer Material --> C[Skin Target Area];
    C -- Dwell Time --> D(Photosensitizer Uptake);
    A --> E(Photodynamic Activation Tip);
    E -- Engage & Deliver Light --> D;
    D -- Photodynamic Reaction --> F[Targeted Cell Destruction/Remodeling];
    E -- (Optional) Deliver Protection --> F;

7.3 Cross-Domain Application: Multi-Stage Biofilm Remediation in Water Pipes

Enabling Description: This method is adapted for the sequential treatment of industrial water pipelines for biofilm remediation. A "first pipe treatment tip" (e.g., a robotic end-effector with an applicator nozzle) engages the inner surface of the pipe to deliver a "first material," which is a highly concentrated biofilm-dispersing chemical agent (e.g., a specific enzyme blend or a non-oxidizing biocide). This chemical loosens and denatures the biofilm structure. After a predetermined contact time, a "second pipe treatment tip" (e.g., a robotic end-effector with a high-pressure water jet nozzle or an abrasive brush array) engages the same treated pipe segment. While the first material is still actively breaking down the biofilm (or immediately after its dwell time), the second tip mechanically scours the pipe surface, effectively removing the weakened biofilm and flushing it away, thus facilitating a more complete remediation.

sequenceDiagram
    participant P as Water Pipe Inner Surface
    participant T1 as Biofilm Dispersing Tip
    participant T2 as Mechanical Scouring Tip
    T1->P: Engage Pipe Surface
    T1->P: Deliver Biofilm Dispersing Chemical
    P->P: Chemical Dwell Time (Biofilm Weakening)
    T2->P: Engage Pipe Surface
    T2->P: Mechanical Scouring (Water Jet/Brush)
    P->P: Biofilm Removal

7.4 Integration with Emerging Tech: AI-Driven Personalized Multi-Stage Facial Treatment

Enabling Description: A method for personalized multi-stage facial treatment leveraging AI and real-time biometric feedback. A "first skin treatment tip" (e.g., a fluidic exfoliation tip) delivers a "first material" (e.g., a lactic acid peel) while integrated IoT sensors (e.g., pH, galvanic skin response, thermography) monitor the skin's reaction. An AI engine (in the console) analyzes this real-time data to determine the optimal duration and intensity of the acid application, predicting the ideal moment for the next stage. Subsequently, a "second skin treatment tip" (e.g., a hydrating massage tip with micro-vibrations) engages the target region. The AI dynamically adjusts the composition and flow rate of a "second material" (e.g., a hydrating serum, antioxidant infusion) delivered by the second tip, based on the immediate post-peel skin condition detected by its own embedded sensors. All treatment parameters, sensor data, AI decisions, and material batch numbers are immutably recorded on a blockchain for a comprehensive, verifiable patient record and compliance auditing.

sequenceDiagram
    participant S as Patient Skin
    participant T1 as Exfoliation Tip (w/ Sensors)
    participant C as Console AI
    participant B as Blockchain Ledger
    participant T2 as Hydration/Massage Tip (w/ Sensors)
    T1->S: Engage Skin
    T1->S: Deliver Lactic Acid Peel
    T1->C: Send pH/GSR/Temp Data
    C->C: Analyze Skin Response & Predict Optimal Transition
    C->T1: Adjust Acid Flow/Duration
    C->B: Log First Stage Treatment
    T2->S: Engage Skin (Post-Peel)
    T2->S: Deliver Hydrating Serum (AI-Adjusted)
    T2->C: Send Post-Peel Skin Data
    C->C: Optimize Second Stage Fluid/Parameters
    C->B: Log Second Stage Treatment

7.5 The "Inverse" or Failure Mode: Sequential Non-Reactive Diagnostic Sampling

Enabling Description: A method for sequential, non-reactive diagnostic sampling of skin components. The "first skin treatment tip" is a gentle, non-abrasive fluid applicator, delivering a "first material" consisting of a sterile, inert solvent (e.g., medical-grade hexane or specific buffer) to the target region. This solvent passively extracts surface lipids or environmental residues for diagnostic analysis, without causing physical exfoliation. The tip immediately collects this fluid. Subsequently, a "second skin treatment tip" engages the same region. This second tip is also non-abrasive and may feature a slightly textured (non-cutting) surface (e.g., a micro-polymer brush) or a hydrophilic membrane. It delivers a "second material" which is a collection buffer or a cellular extraction medium, with very low vacuum. The purpose is to gently collect superficial keratinocytes or a deeper, non-invasive fluid sample facilitated by the initial solvent's action, but without causing any further exfoliation or abrasion. The system incorporates fail-safe force sensors on both tips, immediately halting all fluid delivery and vacuum if any unexpected pressure or skin deformation is detected, ensuring diagnostic integrity and patient safety.

sequenceDiagram
    participant S as Patient Skin
    participant T1 as Solvent Applicator Tip
    participant T2 as Sample Collection Tip
    T1->S: Engage Skin (Gentle)
    T1->S: Deliver Inert Solvent (Material 1)
    S->S: Passive Extraction of Surface Analytes
    T1->S: Collect Solvent/Analytes
    T2->S: Engage Skin (Gentle)
    T2->S: Deliver Collection Buffer (Material 2)
    S->S: Gentle Collection of Cells/Fluid (No Exfoliation)
    T2->S: Collect Buffer/Sample
    T1, T2->S: Force Sensor (Failsafe for no abrasion)

Combination Prior Art Scenarios with Open-Source Standards

Here are at least three "Combination Prior Art" scenarios where the concepts of US Patent 11446477 could be combined with existing open-source standards to demonstrate obviousness of further incremental improvements.

1. Integration with Open-Source Robotics Operating System (ROS) for Automated Treatment

Scenario: Combining the core apparatus (console, handpiece, fluid management) of US11446477 with the Robot Operating System (ROS), an open-source framework for robotic applications.
Description: A system wherein the handpiece assembly (18) and its associated fluid delivery/removal functions are mounted on a robotic arm. The console (12) (or a connected computer) runs ROS, allowing for standardized control of the robotic arm's kinematics, path planning, and real-time interaction with the skin. The manifold system (24) for fluid selection and pumping is interfaced with ROS via standard serial communication protocols (e.g., UART or Ethernet with a ROS serial bridge). An open-source computer vision library (e.g., OpenCV) could be integrated within ROS to perform real-time skin topography analysis, enabling the robotic arm to adapt treatment paths and forces dynamically. The definition of "treatment material" and "skin treatment" within US11446477 would be directly applied to robotic application scenarios. A POSA familiar with both automated systems and skin treatment would find it obvious to apply a ROS-controlled robotic arm to execute the described skin treatment methods and apparatus functions.

2. Standardized Fluid Cartridge Interface based on Open-Source Pharma/Bio-Containers

Scenario: Adapting the manifold system (32) and fluid sources (bottles 26) to utilize or be compatible with open-source standards for pharmaceutical or biological fluid containers, combined with a standardized data exchange format.
Description: The manifold system (24) of US11446477 is redesigned to accept fluid sources (26) that conform to an open-source standard for medical or laboratory consumables, such as the ANSI/SLAS Microplate Standards for modular liquid handling or even conceptually similar to open-source designs for standardized fluid bags/pouches with universal connectors (e.g., those emerging from DIY bio-hardware communities). Each fluid source would include an open-source readable identifier (e.g., a QR code or NFC tag conforming to a public specification like GS1 or an open-source variant) that contains metadata about the treatment fluid (type, concentration, expiry). The console (12) and manifold system (24) parse this data using open-source libraries (e.g., zbar for QR codes, libnfc for NFC) and utilize it for automated selection, dosage control, and logging. This combination makes the "releasably receiving bottles" and "delivering fluid" aspects obvious by applying existing modular fluid handling and data standards.

3. Open-Source Healthcare Data Integration for Personalized Protocols

Scenario: Integrating the treatment data generated by the US11446477 system into open-source electronic health record (EHR) or patient data management standards.
Description: The console (12) of the skin treatment system generates comprehensive treatment data, including fluid types, dosages, treatment duration, specific tip (34) used, and patient response metrics (if sensors are present). This data is formatted and transmitted using open-source healthcare data standards such as Fast Healthcare Interoperability Resources (FHIR) or OpenEHR. Open-source APIs and SDKs for FHIR or OpenEHR are used to integrate the treatment records into a broader patient profile, allowing for personalized treatment protocols that can be accessed and updated across different healthcare providers or systems. For instance, an open-source AI model for dermatology could analyze the FHIR data to recommend optimized sequences for the "method using two tips sequentially" (Claim 36) based on aggregated patient outcomes. This demonstrates the obviousness of integrating device-generated data into a larger, interoperable healthcare ecosystem.

Generated 5/19/2026, 12:47:13 PM